Zasocitinib is an investigational, once-daily, highly selective oral tyrosine kinase 2 inhibitor being developed for immune-mediated inflammatory diseases.

Retatrutide beneficial as a monotherapy in adults with T2D inadequately controlled with diet and exercise alone.

A new extended maintenance regimen for Ebglyss has been approved for eligible patients with moderate to severe atopic dermatitis.

For more than one drink per occasion, higher consumption was associated with progressively increased risks for breast cancer, cardiovascular disease, and injury. HealthDay News — Two drinks per day is ...

For months at Erlanger, Sentri7 failed to raise alarms, overlooking missing drugs and other “inconsistencies” that “should have been flagged,” the nursing board’s order states.

The FDA linked 12 severe kidney complications to alli between 2007 and 2023, resulting in 8 hospitalizations and 5 patients requiring dialysis. The Food and Drug Administration (FDA) has updated the ...

For adults with type 2 diabetes receiving guideline-directed renin-angiotensin inhibitors (RASi) and sodium-glucose cotransporter-2 inhibitors (SGLT2i), dihydropyridine calcium-channel-blocker (DCCB) ...

A wearable ultrasound patch can provide continuous, real-time information about blood flow in the fetus and umbilical cord, according to a study published online May 26 in Nature Biotechnology. Geonho ...

The over-the-counter softgels are used to relieve pressure, bloating, and fullness by rapidly breaking up gas bubbles in the ...

Bemotrizinol is a newly approved over-the-counter sunscreen active ingredient that offers broad-spectrum protection with low systemic absorption.

Significantly longer time seen to first flare that required rescue therapy, and significant benefit seen in all secondary end points.

The phase 3 trial is evaluating the long-term effects of sibeprenlimab-szsi on kidney function in adults with primary immunoglobulin A nephropathy.